Search results for "Opioid-induced constipation"


 
Results 1 - 8 of about 8 for "Opioid-induced constipation".

Mu-opioid receptor antagonists appear safe, effective for opioid-induced constipation, review finds | ACP Gastroenterology Monthly

Researchers looked at randomized controlled trials of peripheral mu-opioid receptor antagonists (methylnaltrexone, naloxone, naloxegol, alvimopan, axelopran, or naldemedine) and the prescription-strength laxatives lubiprostone or prucalopride.

Drug options available for opioid-induced constipation | ACP Gastroenterology Monthly

Four FDA-approved drugs for opioid-induced constipation form the backbone of treatment, with more options in the research pipeline.

AGA issues guideline on opioid-induced constipation | ACP Gastroenterology Monthly

Opioid-induced constipation differs mechanistically from other forms of the disorder, and its medical management deserves dedicated attention, the American Gastroenterological Association (AGA) said.

Naloxone, naldemedine appear best for opioid-induced constipation after laxatives | ACP Gastroenterology Monthly

A meta-analysis found naloxone to have the highest efficacy and safety of pharmacological therapies for opioid-induced constipation, and previous research has shown it to be cost-effective, study authors said.

May 25, 2018 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

October 26, 2018 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

April 27, 2018 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

February 23, 2018 | ACP Gastroenterology Monthly

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   Next